NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
$1.68-$0.30 (-15.15%) Today
Latest NMTC Insider Trades
Mark Christianson - OfficerOpen-market sale
Mark Christianson - OfficerMark Christianson - OfficerMark Christianson - OfficerMark Christianson - OfficerMark Christianson - OfficerMark Christianson - OfficerMark Christianson - OfficerNeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 10,000 | $32K |
| Grant or award | 5 | 143,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Emily J. Johns - Officer | Grant or award | Option to Purchase Common Stock | 12,500 | $0.00 | - | |
| Christopher Volker - Officer | Grant or award | Option to Purchase Common Stock | 35,000 | $0.00 | - | |
| Mark Christianson - Officer | Grant or award | Option to Purchase Common Stock | 12,500 | $0.00 | - | |
| Steve Mertens - Officer | Grant or award | Option to Purchase Common Stock | 15,000 | $0.00 | - | |
| David A. Rosa - Officer | Grant or award | Option to Purchase Common Stock | 68,000 | $0.00 | - | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 10,000 | $3.18 | $32K | |
| Jason Richard Mills - Director | Grant or award | Common Stock | 41,929 | $0.00 | - | |
| Jason Richard Mills - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
 Jeffrey S. Mathiesen - Director | Grant or award | Common Stock | 41,929 | $0.00 | - | |
| Jeffrey S. Mathiesen - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| Paul Buckman - Director | Grant or award | Common Stock | 41,929 | $0.00 | - | |
| Paul Buckman - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| Edward Andrle - Director | Grant or award | Common Stock | 41,929 | $0.00 | - | |
| Edward Andrle - Director | Grant or award | Option to Purchase Common Stock | 26,036 | $0.00 | - | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 15,363 | $4.44 | $11K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $4.66 | $197 | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $4.66 | $704 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $4.66 | $2K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 817 | $4.80 | $654 | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 100 | $4.80 | $80 | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 11,611 | $4.80 | $9K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 2,109 | $4.80 | $2K | |
| David J. Wambeke - Officer | Open-market purchase | Common Stock | 1,000,000 | $4.02 | $670K | |
| David J. Wambeke - Officer | Grant or award | Option to Purchase Common Stock | 500,000 | $0.00 | - | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 7,376 | $4.08 | $5K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 1,812 | $4.08 | $1K | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 71,325 | $4.08 | $49K | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $5.33 | $805 | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $5.33 | $225 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $5.33 | $2K | |
| Mark Christianson - Officer | Open-market sale | Common Stock | 30,000 | $4.44 | $22K | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 906 | $4.07 | $614 | |
| David A. Rosa - Officer | Tax withholding / forfeiture | Common Stock | 2,458 | $4.07 | $2K | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 253 | $4.07 | $172 | |
| Paul Buckman - Director | Grant or award | Option to Purchase Common Stock | 50,000 | $0.00 | - | |
| Jeffrey S. Mathiesen - Director | Grant or award | Option to Purchase Common Stock | 50,000 | $0.00 | - | |
| Mark Christianson - Officer | Tax withholding / forfeiture | Common Stock | 90 | $3.74 | $56 | |
| Steve Mertens - Officer | Tax withholding / forfeiture | Common Stock | 252 | $3.74 | $157 |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) had 6 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for NMTC runs to 37 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NMTC were filed in the last 90 days. 1 purchase is on record for this company.
1 insider sale of NMTC was filed in the last 90 days, totaling $32K.
This page tracks NMTC Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NMTC to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
